Jan Godziński

4.5k total citations
90 papers, 2.2k citations indexed

About

Jan Godziński is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jan Godziński has authored 90 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 46 papers in Molecular Biology and 28 papers in Surgery. Recurrent topics in Jan Godziński's work include Renal and related cancers (44 papers), Renal cell carcinoma treatment (27 papers) and Sarcoma Diagnosis and Treatment (20 papers). Jan Godziński is often cited by papers focused on Renal and related cancers (44 papers), Renal cell carcinoma treatment (27 papers) and Sarcoma Diagnosis and Treatment (20 papers). Jan Godziński collaborates with scholars based in Poland, Germany and France. Jan Godziński's co-authors include Norbert Graf, Bengt Sandstedt, Jan de Kraker, Harm van Tinteren, Marry M. van den Heuvel‐Eibrink, Christophe Bergeron, Gordan Vujanić, Kathy Pritchard‐Jones, Ewa Bień and Daniel Orbach and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Godziński

83 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Godziński Poland 29 1.3k 1.2k 560 555 338 90 2.2k
John A. Kalapurakal United States 32 1.7k 1.3× 1.4k 1.1× 872 1.6× 376 0.7× 283 0.8× 139 3.1k
Edward S. Baum United States 21 899 0.7× 1.2k 1.0× 488 0.9× 334 0.6× 543 1.6× 42 2.6k
Luigi Piva Italy 29 651 0.5× 928 0.8× 181 0.3× 1.8k 3.3× 389 1.2× 130 2.6k
Mojgan Devouassoux‐Shisheboran France 29 589 0.5× 951 0.8× 209 0.4× 632 1.1× 767 2.3× 146 2.9k
Annie Rey France 40 590 0.5× 2.4k 2.0× 222 0.4× 1.5k 2.7× 1.0k 3.0× 78 4.7k
M Brunat-Mentigny France 30 474 0.4× 1.0k 0.9× 200 0.4× 426 0.8× 498 1.5× 96 2.1k
Nicola Nicolai Italy 29 526 0.4× 771 0.6× 111 0.2× 2.4k 4.4× 302 0.9× 159 2.8k
Marco Carini Italy 28 1.3k 1.0× 2.2k 1.8× 154 0.3× 818 1.5× 318 0.9× 116 2.6k
Walter Albrecht Austria 14 1.3k 1.0× 2.1k 1.7× 139 0.2× 1.5k 2.8× 275 0.8× 34 3.1k
A. Rey France 24 338 0.3× 649 0.5× 99 0.2× 602 1.1× 275 0.8× 55 1.7k

Countries citing papers authored by Jan Godziński

Since Specialization
Citations

This map shows the geographic impact of Jan Godziński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Godziński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Godziński more than expected).

Fields of papers citing papers by Jan Godziński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Godziński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Godziński. The network helps show where Jan Godziński may publish in the future.

Co-authorship network of co-authors of Jan Godziński

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Godziński. A scholar is included among the top collaborators of Jan Godziński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Godziński. Jan Godziński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garnier, Hanna, Maciej Murawski, Mamdoh Al‐Ameri, et al.. (2025). Practical Guidelines for the Use of Indocyanine Green in Different Branches of Pediatric Surgery: A Polish Nationwide Multi‐Center Retrospective Cohort Study. Health Science Reports. 8(3). e70586–e70586. 3 indexed citations
2.
Abele, Michael, Calogero Virgone, Tal Ben‐Ami, et al.. (2025). NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT). Lung Cancer. 201. 108449–108449. 1 indexed citations
3.
Glick, Richard D., Rodrigo Romao, Max Pachl, et al.. (2024). Current surgical approaches to pediatric renal tumors. Pediatric Blood & Cancer. 72(S2). e31118–e31118. 2 indexed citations
4.
Roganović, Jelena, Calogero Virgone, Tal Ben Ami, et al.. (2024). Paediatric very rare tumours registration and management in European countries with low health expenditure average rates. Clinical & Translational Oncology. 27(4). 1779–1788. 2 indexed citations
5.
Tracy, Elisabeth T., Marcio H. Malogolowkin, Amos Hong Pheng Loh, et al.. (2023). Nephron sparing surgery and surgical management of intravascular extension of Wilms tumor. Pediatric Blood & Cancer. 70(S2). e30338–e30338. 1 indexed citations
6.
Virgone, Calogero, Tal Ben Ami, Jelena Roganović, et al.. (2023). Age-related biological differences in children’s and adolescents’ very rare tumors. SHILAP Revista de lepidopterología. 2. 100027–100027. 1 indexed citations
7.
Roganović, Jelena, Ewa Bień, Andrea Ferrari, et al.. (2023). Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC). SHILAP Revista de lepidopterología. 2. 100130–100130. 1 indexed citations
8.
Schneider, Dominik T., Andrea Ferrari, Daniel Orbach, et al.. (2023). A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT). SHILAP Revista de lepidopterología. 3. 100137–100137. 4 indexed citations
9.
Schneider, Dominik T., Daniel Orbach, Calogero Virgone, et al.. (2023). Salivary gland carcinomas in children and adolescents: A retrospective analysis of the European Cooperative Study Group for Pediatric Rare Tumours (EXPeRT). SHILAP Revista de lepidopterología. 2. 100129–100129. 4 indexed citations
10.
Krawczyk, Małgorzata, Carla Fernandez, Rita Alaggio, et al.. (2023). Focus on melanotic neuroectodermal tumor of infancy. SHILAP Revista de lepidopterología. 3. 100141–100141. 1 indexed citations
11.
Orbach, Daniel, Ines B. Brecht, Nadège Corradini, et al.. (2023). The role of cancer predisposition syndrome in children and adolescents with very rare tumours. SHILAP Revista de lepidopterología. 2. 100023–100023. 3 indexed citations
12.
Spreafico, Filippo, Ronald R. de Krijger, Jarno Drost, et al.. (2021). Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancers. 13(13). 3142–3142. 34 indexed citations
13.
Schneider, Dominik T., Daniel Orbach, Tal Ben Ami, et al.. (2021). Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. Pediatric Blood & Cancer. 68(S4). e29017–e29017. 11 indexed citations
14.
Virgone, Calogero, Jelena Roganović, Peter Vorwerk, et al.. (2021). Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric Blood & Cancer. 68(S4). e29025–e29025. 28 indexed citations
15.
Stachowicz‐Stencel, Teresa, Anna Synakiewicz, Andrea Ferrari, et al.. (2021). Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric Blood & Cancer. 68(S4). e29042–e29042. 3 indexed citations
16.
Ferrari, Andrea, Dominik T. Schneider, Gianni Bisogno, et al.. (2021). Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements. Pediatric Blood & Cancer. 68(S4). e28993–e28993. 16 indexed citations
17.
Irtan, Sabine, Harm van Tinteren, Norbert Graf, et al.. (2019). Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. European Journal of Cancer. 116. 13–20. 21 indexed citations
18.
Graf, Norbert, Harm van Tinteren, Christophe Bergeron, et al.. (2012). Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. European Journal of Cancer. 48(17). 3240–3248. 61 indexed citations
19.
Pritchard‐Jones, Kathy, Norbert Graf, Christophe Bergeron, et al.. (2011). Doxorubicin can be safely omitted from the treatment of stage II/III, intermediate risk histology wilms tumour: results of the siop wt 2001 randomised trial [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 1 indexed citations
20.
Graf, Norbert, Harm van Tinteren, Kathy Pritchard‐Jones, et al.. (2011). Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026